FGF117360 Clinical study using drug GSK3052230 in Subjects with Cancer

• Research type

  Research Study

• Full title

  FGF117360: Multi-arm, Non-randomized, Open-Label Phase IB Study to Evaluate GSK3052230 in Combination with Paclitaxel and Carboplatin, or Docetaxel or as Single Agent in Subjects with Solid Malignancies and Deregulated FGF Pathway Signalling

• IRAS ID

  135062

• Contact name

  Vanessa Potter

• Contact email

  Vanessa.Potter@nuh.nhs.uk

• Eudract number

  2013-000354-21

• Clinicaltrials.gov Identifier

  NCT01868022

• REC name

  East of England - Essex Research Ethics Committee

• REC reference

  13/EE/0345

• Date of REC Opinion

  25 Nov 2013

• REC opinion

  Further Information Favourable Opinion